324 related articles for article (PubMed ID: 31051317)
1. Abaloparatide improves cortical geometry and trabecular microarchitecture and increases vertebral and femoral neck strength in a rat model of male osteoporosis.
Besschetnova T; Brooks DJ; Hu D; Nagano K; Nustad J; Ominsky M; Mitlak B; Hattersley G; Bouxsein ML; Baron R; Lanske B
Bone; 2019 Jul; 124():148-157. PubMed ID: 31051317
[TBL] [Abstract][Full Text] [Related]
2. Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption.
Chandler H; Lanske B; Varela A; Guillot M; Boyer M; Brown J; Pierce A; Ominsky M; Mitlak B; Baron R; Kostenuik P; Hattersley G
Bone; 2019 Mar; 120():148-155. PubMed ID: 30343166
[TBL] [Abstract][Full Text] [Related]
3. Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia.
Chandler H; Brooks DJ; Hattersley G; Bouxsein ML; Lanske B
Osteoporos Int; 2019 Aug; 30(8):1607-1616. PubMed ID: 31053927
[TBL] [Abstract][Full Text] [Related]
4. Six Weeks of Daily Abaloparatide Treatment Increased Vertebral and Femoral Bone Mineral Density, Microarchitecture and Strength in Ovariectomized Osteopenic Rats.
Bahar H; Gallacher K; Downall J; Nelson CA; Shomali M; Hattersley G
Calcif Tissue Int; 2016 Nov; 99(5):489-499. PubMed ID: 27395059
[TBL] [Abstract][Full Text] [Related]
5. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.
Doyle N; Varela A; Haile S; Guldberg R; Kostenuik PJ; Ominsky MS; Smith SY; Hattersley G
Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289
[TBL] [Abstract][Full Text] [Related]
6. One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption.
Varela A; Chouinard L; Lesage E; Smith SY; Hattersley G
J Bone Miner Res; 2017 Jan; 32(1):24-33. PubMed ID: 27748532
[TBL] [Abstract][Full Text] [Related]
7. One year of abaloparatide, a selective peptide activator of the PTH1 receptor, increased bone mass and strength in ovariectomized rats.
Varela A; Chouinard L; Lesage E; Guldberg R; Smith SY; Kostenuik PJ; Hattersley G
Bone; 2017 Feb; 95():143-150. PubMed ID: 27894941
[TBL] [Abstract][Full Text] [Related]
8. Abaloparatide treatment increases bone formation, bone density and bone strength without increasing bone resorption in a rat model of hindlimb unloading.
Teguh DA; Nustad JL; Craven AE; Brooks DJ; Arlt H; Hu D; Baron R; Lanske B; Bouxsein ML
Bone; 2021 Mar; 144():115801. PubMed ID: 33338664
[TBL] [Abstract][Full Text] [Related]
9. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
[TBL] [Abstract][Full Text] [Related]
10. Abaloparatide, a PTH receptor agonist with homology to PTHrP, enhances callus bridging and biomechanical properties in rats with femoral fracture.
Lanske B; Chandler H; Pierce A; Brown J; Ominsky M; Kostenuik P; Hattersley G
J Orthop Res; 2019 Apr; 37(4):812-820. PubMed ID: 30790359
[TBL] [Abstract][Full Text] [Related]
11. Odanacatib Restores Trabecular Bone of Skeletally Mature Female Rabbits With Osteopenia but Induces Brittleness of Cortical Bone: A Comparative Study of the Investigational Drug With PTH, Estrogen, and Alendronate.
Khan MP; Singh AK; Singh AK; Shrivastava P; Tiwari MC; Nagar GK; Bora HK; Parameswaran V; Sanyal S; Bellare JR; Chattopadhyay N
J Bone Miner Res; 2016 Mar; 31(3):615-29. PubMed ID: 26391310
[TBL] [Abstract][Full Text] [Related]
12. Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice.
Arlt H; Mullarkey T; Hu D; Baron R; Ominsky MS; Mitlak B; Lanske B; Besschetnova T
Bone Rep; 2020 Dec; 13():100291. PubMed ID: 32637467
[TBL] [Abstract][Full Text] [Related]
13. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
[TBL] [Abstract][Full Text] [Related]
14. Effect of parathyroid hormone on hypogonadism induced bone loss of proximal femur of orchiectomized rat.
Tezval M; Serferaz G; Rack T; Kolios L; Sehmisch S; Schmelz U; Tezval H; Stuermer KM; Stuermer EK
World J Urol; 2011 Aug; 29(4):529-34. PubMed ID: 21298272
[TBL] [Abstract][Full Text] [Related]
15. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia.
Duong LT; Crawford R; Scott K; Winkelmann CT; Wu G; Szczerba P; Gentile MA
Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
17. Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis.
Dempster DW; Zhou H; Rao SD; Recknor C; Miller PD; Leder BZ; Annett M; Ominsky MS; Mitlak BH
J Bone Miner Res; 2021 Apr; 36(4):644-653. PubMed ID: 33434314
[TBL] [Abstract][Full Text] [Related]
18. Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
Bilezikian JP; Hattersley G; Fitzpatrick LA; Harris AG; Shevroja E; Banks K; Leder BZ; Zanchetta JR; Hans D
Osteoporos Int; 2018 Feb; 29(2):323-328. PubMed ID: 29167971
[TBL] [Abstract][Full Text] [Related]
19. Teriparatide and Abaloparatide Have a Similar Effect on Bone in Mice.
Brent MB; Stoltenborg FE; Brüel A; Thomsen JS
Front Endocrinol (Lausanne); 2021; 12():628994. PubMed ID: 33953694
[TBL] [Abstract][Full Text] [Related]
20. Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats.
Stolina M; Dwyer D; Niu QT; Villasenor KS; Kurimoto P; Grisanti M; Han CY; Liu M; Li X; Ominsky MS; Ke HZ; Kostenuik PJ
Bone; 2014 Oct; 67():305-13. PubMed ID: 25093263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]